$SRNE News Article - Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB(TM) Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic
https://marketwirenews.com/news-releases/sorr...78532.html